Abeona Therapeutics Lands $750,000 Seed Financing Round

  • Feed Type
  • Date
    12/17/2013
  • Company Name
    Abeona Therapeutics
  • Mailing Address
    11471 Euclid Ave. Cleveland, OH 44106
  • Company Description
    Abeona was founded in March 2013 to develop therapies for patients with lysosomal storage diseases. Abeona has exclusive rights to develop it’s two lead products, ABX-A and ABX-B, for Sanfilippo syndrome based on therapies developed by scientists at Nationwide Children’s Hospital.
  • Website
    http://www.abeonatherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $750,000
  • Transaction Round
    Seed
  • Proceeds Purposes
    The support from multiple international foundations with a mandate for identifying lead Sanfilippo therapies enables us to complete preclinical development and sets the stage to enter clinical trials in 2014.
  • M&A Terms
  • Venture Investor
    Children’s Medical & Research Foundation
  • Venture Investor
    Team Sanfilippo
  • Venture Investor
    Stop Sanfilippo
  • Venture Investor
    Fondation Sanfilippo

Trending on Xconomy